Where are peptides being studied? Explore registered human studies by product, phase, condition and location — from early development through Phase 4, alongside studies where phase does not apply.
Searchable results come from ClinicalTrials.gov and include international sites. For broader coverage, use the worldwide and regional registries below. No single registry captures every study.
Enter a peptide, product, condition or location. Try generic names, brand names and development codes separately. Results are registry search matches, not automatically verified links to a WPF peptide record.
Search terms are sent to ClinicalTrials.gov and appear in the page URL. Do not enter personal or medical identifying information. Registry records are served with up to a one-hour cache; registry updates themselves can lag real-world changes.
Registry search results
Matching records; showing 20 on this page, newest registry updates first. Search checked 2026-11-08 20:25 UTC. Counts are registry matches, not unique peptides or a worldwide total.
Start: 2001-05. Completion: 2008-05 (may be estimated). Results are posted in this registry.
Products and interventions (5)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
carboplatin (drug)
estramustine (drug)
paclitaxel (drug)
radiation therapy (radiation)
leuprolide or goserelin acetate (drug)
Where the study takes place — 23 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Explore the world’s study registries
These links open external registries; their records are not merged into the results above. WHO ICTRP provides a broader search across contributing registries. Search the same generic name, aliases and development codes in relevant regions. One multinational study may appear in more than one registry, so compare registration identifiers before counting it twice.
Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington D.C., District of Columbia, United States Site recruitment: Not reported
Walter Reed Army Medical Center Washington D.C., District of Columbia, United States Site recruitment: Not reported
Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States Site recruitment: Not reported
Veterans Affairs Medical Center - Baltimore Baltimore, Maryland, United States Site recruitment: Not reported
UMASS Memorial Cancer Center - University Campus Worcester, Massachusetts, United States Site recruitment: Not reported
Saint Luke's Hospital Chesterfield, Missouri, United States Site recruitment: Not reported
University Medical Center of Southern Nevada Las Vegas, Nevada, United States Site recruitment: Not reported
CCOP - Nevada Cancer Research Foundation Las Vegas, Nevada, United States Site recruitment: Not reported
Memorial Sloan-Kettering Cancer Center New York, New York, United States Site recruitment: Not reported
Oswego Hospital Oswego, New York, United States Site recruitment: Not reported
CCOP - Hematology-Oncology Associates of Central New York Syracuse, New York, United States Site recruitment: Not reported
SUNY Upstate Medical University Hospital Syracuse, New York, United States Site recruitment: Not reported
Veterans Affairs Medical Center - Syracuse Syracuse, New York, United States Site recruitment: Not reported
Community General Hospital of Greater Syracuse Syracuse, New York, United States Site recruitment: Not reported
Wayne Memorial Hospital, Incorporated Goldsboro, North Carolina, United States Site recruitment: Not reported
Wayne Radiation Oncology Goldsboro, North Carolina, United States Site recruitment: Not reported
Lenoir Memorial Cancer Center Kinston, North Carolina, United States Site recruitment: Not reported
Wilson Medical Center Wilson, North Carolina, United States Site recruitment: Not reported
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States Site recruitment: Not reported
Roper St. Francis Cancer Center at Roper Hospital Charleston, South Carolina, United States Site recruitment: Not reported
Bon Secours St. Francis Health System Greenville, South Carolina, United States Site recruitment: Not reported
CCOP - Greenville Greenville, South Carolina, United States Site recruitment: Not reported
Danville Regional Medical Center Danville, Virginia, United States Site recruitment: Not reported
Start: 2014-12. Completion: 2016-06 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Lucrin depot (drug)
OCP (drug)
Natural (other)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Antalya IVF Antalya, Antalya, Turkey (Türkiye) Site recruitment: Not reported
Start: 2009-01. Completion: 2012-12 (may be estimated). No results posted in this registry response.
Products and interventions (4)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
bicalutamide (drug)
everolimus (drug)
leuprolide acetate (drug)
external beam radiation therapy (radiation)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Montpellier, France Site recruitment: Not reported
Start: 2015-05. Completion: 2016-05 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
COOL-COS (drug) — also listed as: Friendly COS
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Setor de Reprodução Humana - HC-FMRP-USP Ribeirão Preto, São Paulo, Brazil Site recruitment: Not reported
Centre for Endocrinology and Reproductive Medicine, Italy
Countries with listed sites
Italy
Registry dates and results
Start: 2013-01. Completion: 2015-07 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
anastrazole (drug)
GnRH analog alone (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Cerm-Hungaria Rome, Italy Site recruitment: Not reported
Start: 2002-09. Completion: 2006-07 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Trelstar (drug) — also listed as: Triptorelin pamoate
Lupron (drug) — also listed as: luprolide acetate for depot suspension
Zoladex (drug) — also listed as: goserelin acetate
Where the study takes place — 11 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Arizona Urologic Specialists Tucson, Arizona, United States Site recruitment: Not reported
Heritage Physician Group - Urology Department Hot Springs, Arkansas, United States Site recruitment: Not reported
California Oncology of the Central Valley Fresno, California, United States Site recruitment: Not reported
San Bernardino Urological Associates Medical Group San Bernardino, California, United States Site recruitment: Not reported
UroSearch Ocala, Florida, United States Site recruitment: Not reported
Scott A Slavis, MD, PC Las Vegas, Nevada, United States Site recruitment: Not reported
Shaukat M Qureshi, MD Pennsville, New Jersey, United States Site recruitment: Not reported
Brooklyn Heights Urology Associates Brooklyn, New York, United States Site recruitment: Not reported
Jazrawi-Atallah, P.C. Brooklyn, New York, United States Site recruitment: Not reported
Albemarle Urology Clinic, PA Albemarle, North Carolina, United States Site recruitment: Not reported
Raj P. Chopra MD, PC Bloomsburg, Pennsylvania, United States Site recruitment: Not reported
Start: 2009-05. Completion: 2014-09 (may be estimated). Results are posted in this registry.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
leuprolide (drug) — also listed as: Lupron
letrozole (drug) — also listed as: Femara
zoledronic acid (drug) — also listed as: Zometa
Where the study takes place — 4 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Colorado Denver, Colorado, United States Site recruitment: Not reported
Beth Israel Deaconess Medical Center Boston, Massachusetts, United States Site recruitment: Not reported
Dana-Farber Cancer Institute Boston, Massachusetts, United States Site recruitment: Not reported
Newton Wellesley Hospital Newton, Massachusetts, United States Site recruitment: Not reported
Start: 2004-08. Completion: 2009-07 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
External beam radiation (radiation)
Lupron (drug)
Casodex (drug)
Where the study takes place — 3 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Seattle Prostate Institute Seattle, Washington, United States Site recruitment: Not reported
Groupe Health Cooperative, Veterans Adminstration Hospital and University of Washington Seattle, Washington, United States Site recruitment: Not reported
Schiffler Cancer Center Wheeling, West Virginia, United States Site recruitment: Not reported
Start: 2001-07. Completion: 2009-03 (may be estimated). Results are posted in this registry.
Products and interventions (5)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
GnRH (drug) — also listed as: LUPRON, ZOLADEX
Ketoconazole (drug) — also listed as: Nizoral
Bicalutamide (drug) — also listed as: Casodex
Testosterone transdermal gel (drug) — also listed as: Androgel
Estrogen transdermal patch (drug) — also listed as: CLIMARA
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Memorial Sloan Kettering Cancer Center New York, New York, United States Site recruitment: Not reported
Start: 2007-08. Completion: 2008-10 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Abraxane (drug)
Leuprolide (drug) — also listed as: Depot Lupron®, LHRH agonist
Bicalutamide (drug) — also listed as: Casodex®, Anti-androgen therapy
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Baylor College of Medicine - Methodist Hospital Houston, Texas, United States Site recruitment: Not reported
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
CDH Proton Center Warrenville, Illinois, United States Site recruitment: Not reported
Procure Proton Therapy Center Oklahoma City, Oklahoma, United States Site recruitment: Not reported
Hampton University Proton Therapy Institute Hampton, Virginia, United States Site recruitment: Not reported
Start: 2006-04. Completion: 2013-01 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Letrozole (drug) — also listed as: Femora
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2005-12. Completion: 2010-03 (may be estimated). Results are posted in this registry.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Leuprorelin acetate (drug) — also listed as: Leuplin SR 11.25 mg for Injection
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
goserelin acetate (drug) — also listed as: ICI-118630, ZDX, Zoladex
Where the study takes place — 2 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States Site recruitment: Not reported
University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States Site recruitment: Not reported
Start: 2012-04. Completion: 2014-12 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
TAP-144-SR(6M) (drug)
TAP-144-SR(3M) (drug)
Where the study takes place — 15 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Facility not reported Nagoya, Aichi-ken, Japan Site recruitment: Not reported
Facility not reported Fukushima, Fukushima, Japan Site recruitment: Not reported
Facility not reported Maebashi, Gunma, Japan Site recruitment: Not reported
Facility not reported Ohta-shi, Gunma, Japan Site recruitment: Not reported
Facility not reported Sapporo, Hokkaido, Japan Site recruitment: Not reported
Facility not reported Isehara-shi, Kanagawa, Japan Site recruitment: Not reported
Facility not reported Yokohama, Kanagawa, Japan Site recruitment: Not reported
Facility not reported Kumamoto, Kumamoto, Japan Site recruitment: Not reported
Facility not reported Kyoto, Kyoto, Japan Site recruitment: Not reported
Facility not reported Nigata-shi, Niigata, Japan Site recruitment: Not reported
Facility not reported Kurashiki-shi, Okayama-ken, Japan Site recruitment: Not reported
Facility not reported Osaka, Osaka, Japan Site recruitment: Not reported
Facility not reported Suita-shi, Osaka, Japan Site recruitment: Not reported
Facility not reported Kita-adachi-gun, Saitama, Japan Site recruitment: Not reported
Facility not reported Shinjuku-ku, Tokyo, Japan Site recruitment: Not reported
Start: 2011-01. Completion: 2013-12 (may be estimated). No results posted in this registry response.
Products and interventions (1)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
ELIGARD 22.5mg (drug) — also listed as: ELIGARD
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Department of Urology,Yonsei University,College of Medicine, Gangnam Severance Hospital Seoul, South Korea Site recruitment: Not reported
Start: 2004-04. Completion: 2007-12 (may be estimated). No results posted in this registry response.
Products and interventions (6)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Cyproterone acetate (drug) — also listed as: Androcur® 50 mg
Medroxyprogesterone acetate (drug) — also listed as: Gestoral® 10 mg
Venlafaxine (drug) — also listed as: Effexor® LP 37.5 mg
Leuprorelin (drug) — also listed as: Enantone® 11.25 mg
Flutamide (drug)
Placebo (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Professor Jacques IRANI Poitiers, Poitiers, France Site recruitment: Not reported
Start: 2000-03. Completion: 2009-06 (may be estimated). No results posted in this registry response.
Products and interventions (3)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Leuprorelin SR (drug) — also listed as: ENANTONE SR
Radiotherapy (radiation)
Flutamide (drug)
Where the study takes place — 1 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Clinique Mutualiste Saint-Etienne, France Site recruitment: Not reported
Start: 1996-12. Completion: 2008-12 (may be estimated). No results posted in this registry response.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
Leuprorelin (drug)
Flutamide (drug)
Where the study takes place — 0 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
The registry does not list facilities in this record. This does not mean the study has no sites.
Start: 2012-03. Completion: 2014-04 (may be estimated). Results are posted in this registry.
Products and interventions (2)
Includes comparators and combinations. A search match is not a verified peptide identity or evidence of benefit.
TAP-144-SR(6M) (drug)
TAP-144-SR(3M) (drug)
Where the study takes place — 16 listed sites
Site status can differ from overall study status. This list includes all reported sites, even when your search specifies one location. Confirm availability and eligibility with the study team through the original record.
Facility not reported Nagoya, Aichi-ken, Japan Site recruitment: Not reported
Facility not reported Chiba, Chiba, Japan Site recruitment: Not reported
Facility not reported Fukuoka, Fukuoka, Japan Site recruitment: Not reported
Facility not reported Maebashi, Gunma, Japan Site recruitment: Not reported
Facility not reported Sapporo, Hokkaido, Japan Site recruitment: Not reported
Facility not reported Kanazawa, Ishikawa-ken, Japan Site recruitment: Not reported
Facility not reported Yokohama, Kanagawa, Japan Site recruitment: Not reported
Facility not reported Sendai, Miyagi, Japan Site recruitment: Not reported
Facility not reported Nigata-shi, Niigata, Japan Site recruitment: Not reported
Facility not reported Osaka, Osaka, Japan Site recruitment: Not reported
Facility not reported Suita-shi, Osaka, Japan Site recruitment: Not reported
Facility not reported Ageo-shi, Saitama, Japan Site recruitment: Not reported
Facility not reported Kita-adachi-gun, Saitama, Japan Site recruitment: Not reported
Facility not reported Shizuoka, Shizuoka, Japan Site recruitment: Not reported
Facility not reported Shinjuku-ku, Tokyo, Japan Site recruitment: Not reported
Facility not reported tabashi City, Tokyo, Japan Site recruitment: Not reported
Registry directory checked October 5, 2026 against the WHO registry network. This is a starting point, not complete coverage of every country or continent. Record availability, language and update schedules vary by registry.